FDA Inspection
Peter Charles Klatsky, M.D., Inc.Peter Charles Klatsky, M.D., Inc. – FDA Inspection, Apr 11, 2022
Record Details
This FDA Inspection record concerns Peter Charles Klatsky, M.D., Inc., with an inspection on April 11, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 11, 2022
- Product Type
- Biologics
View Company Profile
ID · daa53203-eefe-4220-b8bf-54b47dca07f2
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1167160
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Peter Charles Klatsky, M.D., Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Peter Charles Klatsky, M.D., Inc.
- FDA Inspection 1270885 - 2025-05-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.